- Home
- TNK vs MDXG Comparison
TNK vs MDXG Comparison
Compare TNK & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNK
- MDXG
- Stock Information
- Founded
- TNK 2007
- MDXG 2006
- Country
- TNK Bermuda
- MDXG United States
- Employees
- TNK N/A
- MDXG N/A
- Industry
- TNK Marine Transportation
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- TNK Consumer Discretionary
- MDXG Health Care
- Exchange
- TNK Nasdaq
- MDXG Nasdaq
- Market Cap
- TNK 1.3B
- MDXG 1.1B
- IPO Year
- TNK 2007
- MDXG N/A
- Fundamental
- Price
- TNK $37.52
- MDXG $9.10
- Analyst Decision
- TNK Buy
- MDXG Strong Buy
- Analyst Count
- TNK 3
- MDXG 5
- Target Price
- TNK $63.67
- MDXG $12.00
- AVG Volume (30 Days)
- TNK 387.0K
- MDXG 814.8K
- Earning Date
- TNK 10-30-2024
- MDXG 10-30-2024
- Dividend Yield
- TNK 2.67%
- MDXG N/A
- EPS Growth
- TNK N/A
- MDXG N/A
- EPS
- TNK 12.18
- MDXG 0.52
- Revenue
- TNK $1,191,502,000.00
- MDXG $342,804,000.00
- Revenue This Year
- TNK N/A
- MDXG $9.56
- Revenue Next Year
- TNK N/A
- MDXG $9.19
- P/E Ratio
- TNK $3.08
- MDXG $18.08
- Revenue Growth
- TNK N/A
- MDXG 10.93
- 52 Week Low
- TNK $36.04
- MDXG $5.47
- 52 Week High
- TNK $74.20
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- TNK 29.52
- MDXG 53.38
- Support Level
- TNK $36.04
- MDXG $9.07
- Resistance Level
- TNK $39.03
- MDXG $9.60
- Average True Range (ATR)
- TNK 1.37
- MDXG 0.32
- MACD
- TNK 0.19
- MDXG -0.16
- Stochastic Oscillator
- TNK 25.78
- MDXG 14.05
About TNK Teekay Tankers Ltd.
Teekay Tankers Ltd is a provider of marine services to the global oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: tanker and ship-to-ship transfer. The vast majority of its revenue comes from the tanker segment, which consists of crude oil and product tankers for different contracts.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.